Compound to Control Presbyopia Symptoms

Optall Vision11 enrolled

Overview

Low dose compose to control presbyopia symptoms

A los dose compound including pilocarpine, brimonidine and oxymetazoline was use to control presbyopia symptoms compared to pilocarpine and brimonidine in low doses.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Presbyopia

Interventions

PBO to control presbyopia symptomsCOMBINATION_PRODUCT

Low dose PBO to control presbyopia symptoms

Eligibility

Sex: ALLMin age: 40 YearsMax age: 60 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * healthy * Presbyopic * 40 - 59 years Exclusion Criteria: * Diabetics * Previous eye surgery * Previous eye disease * \> 0.50 myopia * \> 1.5 hyperopia or astigmatism

Locations (1)

Optall Vision

Mexico City, Mexico

Outcomes

Primary Outcomes

Jaeger notation near uncorrected visual acuity change

Number of lines improved 1 hour after drug instillation

Time frame: 1 hour

Comparison of PBO compound Jaeger notation improvement vs Pilocarpine or Brimonidine alone

Number of lines improve comparing PBO compound vs Pilocarpine or Brimonidine

Time frame: 1 hour

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.